α-Lipoic acid normalizes nociceptive neuronal activity at the spinal cord of diabetic rats

Diabetes, Obesity and Metabolism

Volumn 13, Issue 8, 2011, Pages 736-741

  Morgado, C ^a   Pereira Terra, P ^a   Tavares, I ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Animal pharmacology; C fos; Diabetes; Diabetes complications; Diabetic neuropathy; Drug mechanism; KCC2; Microglia; Pain; Spinal cord; Type 1 diabetes; lipoic acid

Indexed keywords

CD11B ANTIGEN; POTASSIUM CHLORIDE COTRANSPORTER; PROTEIN FOS; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HYPERALGESIA; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SPINAL CORD; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

EID: 79959411442     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01399.x     Document Type: Article

References (30)

1. Lin J, Bierhaus A, Bugert P et al. Effects of R-(+)-α-lipoic acid on experimental diabetic retinopathy. Diabetologia 2006; 49: 1089-1096.
2. Obrosova IG, Fathallah I, Lie E, Nourooz-Zadeh J. Early oxidative stress in the diabetic kidney:effect of DL-alpha-lipoic acid. Free Radic Biol Med 2003; 34: 186-195.
3. Stevens MJ, Obrosova I, Cao X, van Huysen C, Greene DA. Effects of DL-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy. Diabetes 2000; 49: 1006-1015.
4. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003; 19: S2-S8.
5. Cameron NE, Jack AM, Cotter MA. Effect of α-lipoic acid on vascular responses and nociception in diabetic rats. Free Radic Biol Med 2001; 31: 125-135.
6. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-250.
7. Borcea V, Nourooz-Zadeh J, Wolff SP et al. Alpha-lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med 1999; 26: 1495-1500.
8. Haak E, Usadel KH, Kusterer K et al. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy. Exp Clin Endocrinol Diabetes 2000; 108: 168-174.
9. Ziegler D, Ametov A, Barinov A et al. Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy. Diabetes Care 2006; 29: 2365-2370.
10. Pop-Busui R, Sima A, Stevens M. Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev 2006; 22: 257-273.
11. Lungu C, Dias JP, França CE et al. Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance. Neuropeptides 2007; 41: 375-387.
12. Morgado C, Tavares I. C-fos expression at the spinal dorsal horn of streptozotocin-induced diabetic rats. Diabetes Metab Res Rev 2007; 23: 644-652.
13. Jolivalt CG, Lee CA, Ramos KM, Calcutt NA. Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters. Pain 2008; 140: 48-57.
14. Morgado C, Pinto-Ribeiro F, Tavares I. Diabetes affects the expression of GABA and potassium chloride cotransporter in the spinal cord: a study in streptozotocin diabetic rats. Neurosci Lett 2008; 438: 102-106.
15. Morgado C, Pereira Terra P, Cruz CD, Tavares I. Minocycline completely reverses mechanical hyperalgesia in diabetic rats through microglia-induced changes in the expression of the potassium chloride co-transporter 2 (KCC2) at the spinal cord. Diabetes Obes Metab 2011; 13: 150-159.
16. Wake H, Watanabe M, Moorhouse AJ et al. Early changes in KCC2 phosphorylation in response to neuronal stress result in functional downregulation. J Neurosci 2007; 27: 1642-1650.
17. Wong A, Dukic-Stefanovic S, Gasic-Milenkovic J et al. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia. Eur J Neurosci 2001; 14: 1961-1967.
18. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-110.
19. Soultanakis RP, Melamede RJ, Bespalov IA et al. Fluorescence detection of 8-oxoguanine in nuclear and mitochondrial DNA of cultured cells using a recombinant Fab and confocal scanning laser microscopy. Free Radic Biol Med 2000; 28: 987-998.
20. Coggeshall RE. Fos, nociception and the dorsal horn. Prog Neurobiol 2005; 77: 299-352.
21. Milligan CE, Cunningham TJ, Levitt P. Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain. J Comp Neurol 1991; 314: 125-135.
22. Tavares I, Lima D, Coimbra A. Neurons in the superficial dorsal horn of the rat spinal cord projecting to the medullary ventrolateral reticular formation express c-fos after noxious stimulation of the skin. Brain Res 1993; 623: 278-286.
23. Payne J, Rivera C, Voipio J, Kaila K. Cation-chloride cotransporters in neuronal communication, development and trauma. Trends Neurosci 2003; 26: 199-206.
24. Coppey LJ, Gellet JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineural arterioles of the sciatic nerve. Diabetes 2001; 50: 1927-1937.
25. Lee WY, Orestes P, Latham J et al. Molecular mechanisms of lipoic acid modulation of T-type calcium channels in pain pathway. J Neurosci 2009; 29: 9500-9509.
26. Messinger RB, Naik AK, Jagodic MM et al. In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 2009; 145: 184-195.
27. Ates O, Cayli SR, Yucel N et al. Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J Clin Neurosci 2007; 14: 256-260.
28. Kabay SC, Ozden H, Guven G et al. Protective effects of vitamin E on central nervous system in streptozotocin-induced diabetic rats. Clin Invest Med 2009; 32: E314-321.
29. Singh U, Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutr Rev 2008; 66: 646-657.
30. Cantuti-Castelvetri I, Shukitt-Hale B, Joseph JA. Neurobehavioral aspects of antioxidants in aging. Int J Dev Neurosci 2000; 18: 367-381.